Exhibit
10.1


 


Convertible
Loan Extension Agreement


 


This
Convertible Loan Extension Agreement (“Extension”) is entered into as of October23, 2022 (the “Extension
Effective Date”), by and between Orgenesis Inc. (“Borrower”) and Yehuda Nir (“Lender”).
Borrower and Lender may each be referred to herein as a “Party,” and collectively as the “Parties”.
Any term not defined herein shall have the meaning ascribed to it in the CN (as defined below).


 


WHEREAS:
Lender and Borrower are parties to that certain Convertible Loan Agreement, dated April 21, 2022, ( “Original Effective
Date”), as amended on May 11, 2022 (“CN”), for the loan amount of US$ 5,000,000 attached hereto as Exhibit
A; and


 


WHEREAS:
Lender and Borrower wish to revise the terms of the CN in accordance with the terms herein;


 


NOW
THEREFORE, the Parties hereby agree as follows:


 


	1	Interest
                                            Rate



 


1.1 Commencing
as of the Original Effective Date, interest shall accrue on the unconverted and then outstanding Loan Amount at the rate of 10% per annum
(“Interest Rate”).


 


	2	Maturity
                                            Date Extension



 


2.1 The Maturity Date under the CN shall be extended from July 21, 2023 to January 20, 2024 (the “Maturity Date”).




 


	3	Warrants



 


3.1 The
Borrower shall issue the Lender a warrant registered in the name of such Lender, or in such nominee name(s) as designated by such Lender,
representing the right to purchase 1,111,111 shares of Common Stock, at an exercise price per share of $2.50 per share. Such warrant
will be exercisable at any time beginning six (6) months and one day after the Extension Effective Date and ending thirty-six (36) months
after the Extension Effective Date.


 


3.2 The
warrant in Section 3.1 above shall be in addition to Warrant dated April 21, 2022 and granted pursuant to Section 1(b) of the CN (the
“Original Warrant”).


 


	4	Conversion
                                            Price.



 


4.1 The
Conversion Price for conversion of the outstanding amount as defined in Section 2(a)a. of the CN shall be amended to “a price per
share of $2.50 per share” instead of $4.50 per share.


 




    	1



     


    

 


	5	Exhibit
                                            A. Exhibit A of the CN shall be amended as follows:



 


	Name of Lender	 	Loan Amount	 	Number of Warrants	 	Date
	Yehuda Nir	 	$	5,000,000	 	 	 	277,778	 	 	 	April 21st, 2022	 
	Yehuda Nir	 	 	 	 	 	 	1,111,111	 	 	 	October 23 , 2022	 
	Total	 	$	5,000,000	 	 	 	1,388,889	 	 	 		 



 


	6	General
                                            Provisions.



 


6.1 The
CN is hereby amended only to the extent necessary to give full effect to this Extension. Unless expressly specified herein, all other
terms and conditions specified in the CN shall apply and shall remain in full force and effect. Capitalized terms used not defined herein
shall have the meaning ascribed to them in the CN. In the event of any conflict between the terms of this Extension and the terms of
the CN, the terms of this Extension shall control. Without limiting the aforesaid, the Borrower hereby represents that all approvals
required with respect to this Extension have been obtained by the Borrower.


 


6.2 This
Extension may be executed in any number of counterparts, including in facsimile and scanned format, each of which shall be deemed an
original and enforceable against the Party actually executing such counterpart and all of which together shall constitute one and the
same instrument.


 


6.3 The
Borrower shall promptly make any and all reports required with respect to this Extension.


 


[Remainder
of Page Intentionally Left Blank]


 




    	2



     


    

 


IN
WITNESS WHEREOF, the Parties have executed this Extension to Convertible Loan Agreement as of the date first above written.


 


THE
LENDER:


 


	/s/ Yehuda Nir	 
	Yehuda Nir	 



  


	ORGENESIS
    INC.	 
	 	               	 
	By:
    	/s/
Vered Caplan	 






	Name:
    	Vered
    Caplan	 
	Title:
    	Chief
    Executive Officer	 






	Address:
    	20271
    Goldenrod Lane	 
	Germantown,
    Maryland, 20776 USA	 


 


[Signature
page to the Extension to Convertible Loan Agreement between Orgenesis Inc. and Yehuda Nir]


 




    	3



     


    

 


Exhibit
A - Convertible Loan Agreement


 




    	4